Kim Min-young, representative of Dong-A Socio Holdings, said on the 2nd, "Today’s international situation and economic crisis present a scenario that is difficult to predict even one step ahead," but he also projected that it could be a year that brings us closer to our goals.
In his New Year's address distributed that day, Kim noted, "In the face of crises in the domestic pharmaceutical industry during the 1980s, such as the opening of imports for finished pharmaceuticals and raw materials, the liberalization of capital, and the early introduction of the material patent system, we established a breakthrough with systematic strategies without giving up amid competition with multinational corporations," and he added, "We built a research and development-centered corporate culture and launched competitive new drugs such as growth hormones, first-generation biopharmaceuticals, styrene, and Zidenan in the global market, laying the groundwork for future growth as a pharmaceutical company focused on research and development."
He emphasized, "This precedent is a success story that illustrates how we have been able to move steadily toward our goals even in times of crisis," and he added, "Even in challenging environments, the DNA of Dong-A Socio Group has consistently created new opportunities through innovation and challenges."
He continued, "As we welcome the Year of the Blue Snake, if all employees draw on wisdom and flexibility to open up new possibilities and navigate the uncertain future wisely, it will be a year that brings us closer to the goals of the group we have set," and he urged, "I hope all employees believe in, encourage, and move forward together from this new starting point."